Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure

Title

Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure

Authors

Keywords

Type 2 diabetes, Cardiovascular outcomes trial, Dipeptidyl peptidase 4 inhibitor (DPP-4i), Sodium glucose linked transporter inhibitor (SGLT2-i) and glucagon like peptide 1 receptor analogues, Myocardial infarction, Stroke, Heart failure, Cardiovascular death, Meta-analysis

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE

Volume 150, Issue -, Pages 8-16

Publisher

Elsevier BV

Online

2019-02-20

DOI

10.1016/j.diabres.2019.02.014